Sort
23,748 grants matching “melanoma”
Project 1--Targeted therapies for pediatric low-grade astrocytoma (Eck/Wright/Haas)
$317,618Michael J Eck · Brigham And Women'S Hospital · P50 · FY2023 · CA
TR&D1: Engineering artificial Antigen Presenting Cells, aAPC, for Adoptive Immunotherapy
$317,580Jonathan P Schneck · Johns Hopkins University · P41 · FY2019 · EB
TR&D1: Engineering artificial Antigen Presenting Cells, aAPC, for Adoptive Immunotherapy
$317,580Jonathan P Schneck · Johns Hopkins University · P41 · FY2022 · EB
TR&D1: Engineering artificial Antigen Presenting Cells, aAPC, for Adoptive Immunotherapy
$317,580Jonathan P Schneck · Johns Hopkins University · P41 · FY2020 · EB
Ligand Recognition by Phospholipid Growth Factor Receptors
$317,552Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2006 · CA
Combinatorial targeting of melanoma initiating cells
$317,529Soldano Ferrone · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · CA
Mechanisms on metastasis and survival in alcoholic mice
$317,514Gary G Meadows · Washington State University · R01 · FY2010 · AA
Cancer Prevention and Treatment by Activation of a Brain-Adipocyte Axis
$317,475Lei Cao · Ohio State University · R01 · FY2013 · CA
Rational combination of EGFR and Hedgehog inhibitors in head and neck cancer
$317,475Antonio Jimeno · University Of Colorado Denver · R21 · FY2011 · CA
Expressing New Tumor Antigens by Inhibition of Nonsense Mediated mRNA Decay
$317,475Eli Gilboa · University Of Miami School Of Medicine · R01 · FY2011 · CA
Plexin signalling in melanocyte biology and melanoma progression
$317,475Glynis A Scott · University Of Rochester · R01 · FY2010 · CA
Expressing New Tumor Antigens by Inhibition of Nonsense Mediated mRNA Decay
$317,475Eli Gilboa · University Of Miami School Of Medicine · R01 · FY2015 · CA
Rational combination of EGFR and Hedgehog inhibitors in head and neck cancer
$317,475Antonio Jimeno · University Of Colorado Denver · R21 · FY2012 · CA
Expressing New Tumor Antigens by Inhibition of Nonsense Mediated mRNA Decay
$317,475Eli Gilboa · University Of Miami School Of Medicine · R01 · FY2012 · CA
Mechanistic studies of gamma-glutamyl transpeptidase inhibition: A novel approach to modulating serum levels of cysteine
$317,467Marie H Hanigan · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2020 · GM
THERAPEUTIC STUDIES--DENDRITIC CELL BASED CANCER VACCINE
$317,436University Of Michigan At Ann Arbor · R01 · FY2001 · CA
A Unified Machine Learning Package for Cancer Diagnosis
$317,390Linda Shapiro · University Of Washington · U01 · FY2019 · CA
Predicting Transcriptional and Epigenetic Networks in Cancer from Sequencing Data
$317,385Jun S Song · University Of Illinois At Urbana-Champaign · R01 · FY2019 · CA
Investigating the PD-L1:NLRP3 signaling axis as a tumor intrinsic mechanism of adaptive resistance to anti-PD-1 antibody immunotherapy
$317,373Brent Allen Hanks · Duke University · R37 · FY2020 · CA
Neuropilin and Semaphorin Function in Development and Tumor Angiogenesis
$317,363Michael Klagsbrun · Boston Children'S Hospital · P01 · FY2010 · CA
Large heat shock proteins and their role in cancer therapy
$317,333Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2019 · CA
Melanocortin-1 Receptor Targeted Ultrasmall Silica nanoparticles for Alpha- and
$317,263Thomas P Quinn · Sloan-Kettering Inst Can Research · U54 · FY2016 · CA
Southwest Oncology Group
$317,259University Of Southern California · U10 · FY2005 · CA
Mechanistic Studies on New Platinum Clinical Agents
$317,250Virginia Commonwealth University · R01 · FY2002 · CA
Administrative and Statistics Core
$317,203Antoni Ribas · University Of California Los Angeles · P01 · FY2021 · CA